A Pharmacokinetics Study of MultiHance in Pediatric Patients

Inclusion Criteria: * Male or female between 2 and 5 years of age * Obtained informed consent from patient's parent or guardian * Obtain assent when applicable according to local law * Known or suspected disease of the central nervous system (brain or spine) * Referred for MRI of the brain or spine requiring an injection of an MR contrast agent Exclusion Criteria: * Contraindications to MR examination * Undergoing MRI in an emergency situation * Known allergy to one or more ingredients in the contrast agent or history of hypersensitivity to gadolinium or metals * Sickle cell anemia * Likely to undergo an invasive examination within 72 hours after administration of the investigational product